Prescription drug · ANDA
Enalapril Maleate NDC 50090-7677
Enalapril maleate 20 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-7677-0 | 50090767700 | 30 TABLET in 1 BOTTLE (50090-7677-0)Marketed from Oct 8, 2025 | |
| 50090-7677-1 | 50090767701 | 60 TABLET in 1 BOTTLE (50090-7677-1)Marketed from Oct 8, 2025 | |
| 50090-7677-3 | 50090767703 | 90 TABLET in 1 BOTTLE (50090-7677-3)Marketed from Oct 8, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Enalapril Maleate
- Generic name (nonproprietary)
- enalapril maleate
- Active ingredients
- Enalapril maleate — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075178
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)
- Identifiers
- Product ID 50090-7677_68698c51-6c2c-425e-a681-fbb382d79968SPL ID 68698c51-6c2c-425e-a681-fbb382d79968SPL set ID fd0a7ecc-d6a2-4e04-a14f-1ed4dacb7df3RxCUI 858810UNII 9O25354EPJ
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090767700followed by a unit qualifier and the quantityPackage 50090-7677-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Hypertension Enalapril maleate tablets, USP are indicated for the treatment of hypertension. Enalapril maleate tablets, USP are effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of enalapril maleate tablets, USP and thiazides are approximately additive. Heart Failure Enalapril maleate tablets, USP are indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. In these patients enalapril maleate tablets, USP improve symptoms, increase survival, and decrease the frequency of hospitalization (see CLINICAL PHARMACOLOGY, H…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 075178
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Enalapril Maleate | Enalapril maleate 10 mg/1 | TabletOral | A-S Medication Solutions | 50090-7678 |
| Enalapril Maleate | Enalapril maleate 2.5 mg/1 | TabletOral | ScieGen Pharmaceuticals, Inc. | 50228-228 |
| Enalapril Maleate | Enalapril maleate 5 mg/1 | TabletOral | ScieGen Pharmaceuticals, Inc. | 50228-229 |
| Enalapril Maleate | Enalapril maleate 10 mg/1 | TabletOral | ScieGen Pharmaceuticals, Inc. | 50228-230 |
| Enalapril Maleate | Enalapril maleate 20 mg/1 | TabletOral | ScieGen Pharmaceuticals, Inc. | 50228-231 |